Venus Remedies Expands Global Presence with New Marketing Approvals

5 Jul 2023 , 01:12 PM

Venus Remedies witnessed a nearly 3 % increase in its share price on July 5 after receiving marketing approvals from four regions abroad. 

The company has consolidated its position in the Gulf Cooperation Council (GCC), Association of South East Asian Nations (ASEAN), Balkan, and Caribbean regions with marketing approvals from Oman, Malaysia, Bosnia, and Trinidad and Tobago.

These approvals pertain to key chemotherapy drugs and contribute to Venus Remedies’ growing presence in these regions. Venus Remedies has now secured a total of 503 marketing approvals for its oncology products across 75 countries.

Saransh Chaudhary, President for Global Critical Care at Venus Remedies, expressed that these marketing approvals will expand the company’s operations to new geographies and provide advanced cancer treatment options with improved outcomes for patients.

Venus Remedies has submitted additional dossiers to the Malaysian Health Ministry for nine marketing authorizations, including pending approvals for two oncology products.

Malaysia, with a significant market size for cancer drugs valued at $417 million in 2019, contributes significantly to Venus Remedies’ revenue from the ASEAN region.

These marketing approvals reflect Venus Remedies’ commitment to meeting unmet medical needs in oncology and critical care segments while striving to provide access to life-saving treatments to more patients worldwide.

For feedback and suggestions, write to us at [e-mail]